We are live on ! Find out more
NEPH icon

Nephros
NEPH

18 hedge funds and large institutions have $4.57M invested in Nephros in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.49% less ownership

Funds ownership: 41.34% → 40.85% (-0.49%)

5% less funds holding

Funds holding: 19 → 18 (-1)

7% less capital invested

Capital invested by funds: $4.94M → $4.57M (-$366K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$41.4K
2
Wells Fargo
Wells Fargo
California
+$1

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$11.8K
2
Renaissance Technologies
Renaissance Technologies
New York
-$10.2K
3
Osaic Holdings
Osaic Holdings
Arizona
-$5.26K
4
Citadel Advisors
Citadel Advisors
Florida
-$3.5K
5
TRCT
Tower Research Capital (TRC)
New York
-$1.97K
Name Holding Trade Value Shares
Change 		Change in
Stake
WC
1
Wexford Capital
Florida
$3.91M – – –
BA
2
Bard Associates
Illinois
$208K -$575 -500 -0.3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$157K – – –
HighTower Advisors
4
HighTower Advisors
Illinois
$60K – – –
EP
5
Elkhorn Partners
Nebraska
$54K – – –
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$39.2K +$41.4K +35,990 New
William Blair & Company
7
William Blair & Company
Illinois
$38.8K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$25K -$10.2K -8,864 -28%
State Street
9
State Street
Massachusetts
$17.1K – – –
Citadel Advisors
10
Citadel Advisors
Florida
$16.7K -$3.5K -3,045 -17%
Morgan Stanley
11
Morgan Stanley
New York
$16.4K – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$12.1K -$266 -231 -2%
TRCT
13
Tower Research Capital (TRC)
New York
$12K -$1.97K -1,712 -13%
BlackRock
14
BlackRock
New York
$4.42K – – –
UBS Group
15
UBS Group
Switzerland
$254 -$11.8K -10,294 -98%
Wells Fargo
16
Wells Fargo
California
$67 +$1 +1 +2%
Osaic Holdings
17
Osaic Holdings
Arizona
$5 -$5.26K -4,569 -100%
MCC
18
Money Concepts Capital
Florida
– -$58 -50 Closed
Bank of America
19
Bank of America
North Carolina
– -$16 -14 Closed

NEPH Hedge Fund Activity: Q1 2023 in Review

18 of the 6,278 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q1 2023, worth a combined $4.57M — down 7.4% from $4.94M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NEPH and 1 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $41.4K. The largest seller was UBS Group, cutting an estimated $11.8K.

  • 18 institutional investors held Nephros (NEPH) as of Q1 2023, down from 19 in Q4 2022.
  • Funds reported $4.57M of Nephros stock for Q1 2023, down 7.4% quarter-over-quarter.
  • 1 fund opened new Nephros positions in Q1 2023 and 2 closed out, a net change of -1 holder.
  • The largest Nephros buyer in Q1 2023 was Susquehanna International Group, an estimated $41.4K added.
  • The largest Nephros seller in Q1 2023 was UBS Group, an estimated $11.8K sold.

Based on aggregated 13F filings for Q1 2023.